share_log

HC Wainwright & Co. Upgrades Onconova Therapeutics to Buy, Announces $11 Price Target

HC Wainwright & Co. Upgrades Onconova Therapeutics to Buy, Announces $11 Price Target

HC Wainwright & Co.將Onconova Therapeutics升級爲買入,宣佈目標價爲11美元
Benzinga ·  2023/04/21 06:48

HC Wainwright & Co. analyst Joseph Pantginis upgrades Onconova Therapeutics (NASDAQ:ONTX) from Neutral to Buy and announces $11 price target.

HC Wainwright & Co. 分析師約瑟夫·潘吉尼斯將Onconova Therapeutics(納斯達克股票代碼:ONTX)從中性上調至買入,並宣佈了11美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論